Biomarkers for Risk Assessment and Prevention of Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|4|482-499

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.4, 2009-06, pp. : 482-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4879-4898

Bentham Science Publishers

Access to resources Recommend Favorite

Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer

By Dienstmann Rodrigo  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 15-25

Adis International

Access to resources Recommend Favorite

A PROPOSED METHODOLOGY OF CANCER RISK ASSESSMENT MODELING USING BIOMARKERS

By Lee Byung Mu   Yoo Sun Dong   Kim Seki  

Journal of Toxicology and Environmental Health, Vol. 65, Iss. 5-6, 2002-03 ,pp. : 341-354

Taylor & Francis Ltd

Access to resources Recommend Favorite

Breast Cancer Risk Assessment: A Guide for Clinicians Using the NCCN Breast Cancer Risk Reduction Guidelines

By Merajver Sofia D.   Milliron Kara  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 297-301

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Raloxifene in breast cancer prevention

By Gennari Luigi   Merlotti Daniela   Paola Vincenzo De   Nuti Ranuccio  

Expert Opinion on Drug Safety, Vol. 7, Iss. 3, 2008-05 ,pp. : 259-270

Informa Healthcare

Access to resources Recommend Favorite